International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

The International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022 took place as a hybrid workshop at the Sercotel Caspe Hotel in Barcelona, Spain, from 19-20 September 2022. Delegates were able to attend either in person in Barcelona or virtually from their computer.

This workshop was the 23rd Edition of the Antiviral PK meeting. A truly historic and important workshop dedicated to understanding the clinical pharmacology of antiviral therapy that is pivotal to designing optimal treatment and prevention strategies.

The International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023 will take place as a hybrid workshop from 11-13 September 2023.

The International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs gathers leading experts to discuss all aspects of the optimal use of antiviral therapy including drug-drug interactions, pharmacokinetics of investigational and existing drugs, pharmacodynamics, drug dosing in underrepresented populations, post-marketing surveillance, and regulatory considerations.

General Information 

• Registration for International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2022 is now closed.

• The registration fee includes access to all (livestream) sessions during the event (19-20 September), as well as access to all presentation materials and recordings three weeks after the event (22 September - 12 October) on the virtual portal.

• Payment can only be made by credit card. If this is not possible for you, please contact the Conference Secretariat via eva.vamvounaki@amededu.com.

• If you have financial concerns or are eligible for a discount, please contact the conference secretariat via eva.vamvounaki@amededu.com.

* To register on the workshop dates and revisit the recordings of the live stream on the virtual portal

** Countries included in the low-income and lower-middle-income economies of the World Bank Classification.

*** Industry and endorser representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us via Rikke.Rode@amededu.com.

If you have financial concerns or are eligible for a discount, please contact the conference secretariat via eva.vamvounaki@amededu.com.

• We strongly advise that you register early to secure your slot. 
• Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full payment has been received (if applicable) and a confirmation of your registration has been sent.
• Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honoured.

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

The members of the Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts and play an active role during the workshop as moderators and/or chairs of sessions.

• Su-Young Choi, PharmD, PhD - Food and Drug Administration, United States
• Angela Colbers, PhD  - Radboud University Medical Center, the Netherlands
• Rodolphe Garraffo, MD - Hopital Pasteur Nice, France
• David Haas, MD - Vanderbilt University Medical Center, United States
• Saye Khoo, MD - University of Liverpool, United Kingdom
• Mohammed Lamorde, MD - Infectious Diseases Institute, Uganda
• Lawrence Lee, MBBS, PhD - National University of Singapore, Singapore
• Minh Patrick Lê, PhD - Hôpital Bichat-Claude Bernard, France
• Catia Marzolini, PharmD, PhD - University Hospital Basel & University of Liverpool, United Kingdom
• Kimberly Struble, PharmD - Food and Drug Administration, United States
• Steve Taylor, MRCP, PhD - Birmingham Heartlands Hospital, United Kingdom
• Catriona Waitt, MBChB, PhD - University of Liverpool, United Kingdom 

The members of the Academic Advisory Board (AAB) are former members of the OC and remain active the in planning of the program for the next year. Members of the current OC are selected from this group. 

• David Back, PhD - University of Liverpool, United Kingdom
• Terrence Blaschke, MD - Stanford University School of Medicine, United States
• David Burger, MD, PhD - Radboud University Medical Center, the Netherlands
• Giovanni Di Perri, MD, PhD - University of Torino, Italy
• Courtney Fletcher, PharmD - University of Nebraska Medical Center, United States
• Charles Flexner, MD - Johns Hopkins University, United States
• Angela Kashuba, PharmD - University of North Carolina at Chapel Hill, United States
• Jennifer Kiser, PharmD, PhD - University of Colorado, United States
• Jürgen Rockstroh, MD - University of Bonn, Germany
• Jonathan Schapiro, MD - National Hemophilia Center, Sheba Medical Center, Israel

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.

• Daria Hazuda - Merck
• Thomas Kakuda - Alios BioPharma
• Charles LaPorte - Janssen Biologics
• Wei Liu - AbbVie
• Parul Patel - ViiV Healthcare
• Marco Siccardi - Labcorp
• Manoli Vourvahis - Pfizer

• Abstract Submission is now closed.
• Registration fees are waived for healthcare professionals from RLS and early-career professionals with an accepted abstract. A 50% discount is offered to healthcare professionals from RLS and early-career professionals without an accepted abstract. The requirements for the application are specified under "Registration".
• Abstracts can be submitted in English.

We invite you to submit your latest study and data in any of the below categories: 

• Drug-Drug Interactions

• Novel Drugs and Formulations

• Pharmacogenetics

• Pharmacokinetics during Pregnancy and Other Key Populations

• PK/PD of Drug Efficacy and Toxicity (including TDM)

• Cellular and Tissue Pharmacokinetics

By submitting an abstract to a meeting organized by Virology Education BV (VE) or Academic Medical Education BV (AME), the abstract submitter hereby agrees to the terms and conditions.

The terms and conditions can be viewed here.

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives involved in Clinical Pharmacology of HIV, Hepatitis, and other Antiviral Drugs.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Rikke Puggaard-Rode at Rikke.Rode@amededu.com.

 
Benefits of Support 
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

• Symposium opportunities
• Non-commercial interviews with company representatives
• Verbal acknowledgment during the program 
• Discounted and complimentary registrations for your representatives
• Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
• Company acknowledgment on printed meeting materials including but not limited to banners and the program book
• Digital and printed advertising opportunities 
• Social media shout-outs
• Logo on the conference bag 

 
*Subject to the support level

• 22nd Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2021, Virtual
• 21st Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2020, Virtual
• 20th Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2019, The Netherlands
• 19th Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2018, United States
• 18th Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2017, United States
• 17th Edition, International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2016, United States

Contribution of Pharmacology to HIV Cure - Angela Kashuba, BScPhm, PharmD, DABCP, FCP

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021